BackSpringWorks Therapeutics Overview

SpringWorks Therapeutics Cost of Revenue

Cost of Revenue analysis for SWTX.

Quarterly Cost of Revenue

$3.53M
↑ 82.65% YoY

As of Mar 31, 2025

Annual Cost of Revenue (TTM)

$15.72M
↑ 237.53% YoY

Trailing 12 months ending Mar 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin